As the earnings season continues, it is a good time for investors to take a look at the performance of some select companies. The medical technology sector leader Brain Scientific Inc (OTCMKTS:BRSF) was in the news yesterday after it announced its financial results for the third fiscal quarter that had ended on September 30, 2021.
On Thursday, BRSF stock decreased 2.55% at $0.2680 with more than 39.30K shares, compared to its average volume of 13.93K shares. The stock has moved within a range of $0.2601 – 0.2800 after opening the trade at $0.2700.
However, at the same time, it should be noted that the financial results did not come as a boost to the stock and it ended the day with a decline of 3%. That took the losses recorded by the stock over the course of the past week to as much as 10%.
In this situation, it might be a good idea to take a closer look at some of the highlights from the financial results. The company managed to bring in product revenues to the tune of as much as $185,000 for the third quarter and that was higher than the $145,000 that it had generated in the prior year period.
On the other hand, the selling, administrative and general expenses soared to $58,000 for the quarter from $380,000 in the prior year period. It remains to be seen if the stock can make a recover today.